Iron and erythropoiesis-stimulating agents in anaemia

Anaemia is a frequent and clinically relevant problem in patients with malignancy and may be aggravated in patients receiving chemotherapy. Blood transfusions, iron supplementation, and erythropoiesis-stimulating agents (ESAs) are established treatment options for anaemic patients.